QT
RCUS icon

Quantbot Technologies’s Arcus Biosciences RCUS Stock Holding History

Quantbot Technologies’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.85K Buy
+125
New +$3.09K ﹤0.01% 1871
2023
Q3 		– Sell
-300
Closed -$6.09K – 1889
2023
Q2 		$6.09K Buy
+300
New +$5.71K ﹤0.01% 1488
2021
Q4 		– Sell
-2,000
Closed -$69K – 1841
2021
Q3 		$69K Buy
+2,000
New +$62.2K 0.01% 1053
2021
Q2 		– Sell
-237
Closed -$6K – 1792
2021
Q1 		$6K Buy
+237
New +$8.25K ﹤0.01% 1286
2020
Q4 		– Sell
-500
Closed -$8K – 1612
2020
Q3 		$8K Buy
+500
New +$11.2K ﹤0.01% 1140

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Quantbot Technologies's RCUS Position: Q2 2026 in Review

Quantbot Technologies opened a new position in Arcus Biosciences (RCUS) in Q2 2026: 125 shares worth $3.85K. The stake represents ﹤0.01% of the portfolio and ranks #1871 among its holdings. This is a return to the name: Quantbot Technologies previously reported a position in RCUS as recently as Q2 2023.

Quantbot Technologies first reported a position in RCUS in Q3 2020 and has held it in 5 quarters since. The position peaked at $69K in Q3 2021. 232 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Quantbot Technologies held 125 shares of Arcus Biosciences worth $3.85K as of Q2 2026.
  • Arcus Biosciences was a new Quantbot Technologies position in Q2 2026.
  • Arcus Biosciences made up ﹤0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1871 holding.
  • Quantbot Technologies first reported a position in Arcus Biosciences in Q3 2020 and has held it in 5 quarters since.
  • Quantbot Technologies's Arcus Biosciences position peaked at $69K in Q3 2021.
  • 232 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.